Temporoparietal hypometabolism in frontotemporal lobar degeneration and associated imaging diagnostic errors

Archives of Neurology

Volumn 68, Issue 3, 2011, Pages 329-337

  Womack, Kyle B ^a,b   Diaz Arrastia, Ramon ^a   Aizenstein, Howard J ^c   Arnold, Steven E ^d   Barbas, Nancy R ^e,f   Boeve, Bradley F ^g   Clark, Christopher M ^d   DeCarli, Charles S ^h   Jagust, William J ⁱ   Leverenz, James B ^k,l   Peskind, Elaine R ^l   Turner, R Scott ^e,f   Zamrini, Edward Y ⁿ   Heidebrink, Judith L ^e,f   Burke, James R ^o   DeKosky, Steven T ^c,r   Farlow, Martin R ^p   Gabel, Matthew J ^q   Higdon, Roger ^m   Kawas, Claudia H ^j   Koeppe, Robert A ^f   Lipton, Anne M ^a,b,s   Foster, Norman L ⁿ   more..

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

^e UNIVERSITY OF MICHIGAN   (United States)

^f UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^g MAYO CLINIC   (United States)

^h UNIVERSITY OF CALIFORNIA   (United States)

ⁱ UNIVERSITY OF CALIFORNIA   (United States)

^j UNIVERSITY OF CALIFORNIA   (United States)

^k UNIVERSITY OF WASHINGTON   (United States)

^l UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^m SEATTLE CHILDREN S HOSPITAL   (United States)

ⁿ UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^o DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^p INDIANA UNIVERSITY   (United States)

^q WASHINGTON UNIVERSITY   (United States)

^r UNIVERSITY OF VIRGINIA   (United States)

^s Presbyterian Hospital   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ALZHEIMER DISEASE; ANTERIOR CINGULATE; ARTICLE; AUTOPSY; BRAIN METABOLISM; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; DIAGNOSTIC TEST ACCURACY STUDY; FRONTAL CORTEX; FRONTOTEMPORAL DEMENTIA; HISTOPATHOLOGY; HUMAN; INTERRATER RELIABILITY; NEUROPATHOLOGY; PARIETAL CORTEX; POSITRON EMISSION TOMOGRAPHY; POSTERIOR CINGULATE; PRIORITY JOURNAL; TEMPORAL CORTEX;

ADULT; AGE OF ONSET; AGED; ALZHEIMER DISEASE; BRAIN; DIAGNOSIS, DIFFERENTIAL; DIAGNOSTIC ERRORS; FEMALE; FLUORODEOXYGLUCOSE F18; FRONTOTEMPORAL LOBAR DEGENERATION; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; OBSERVER VARIATION; PARIETAL LOBE; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; TEMPORAL LOBE;

EID: 79952578268     PISSN: 00039942     EISSN: 15383687     Source Type: Journal    
DOI: 10.1001/archneurol.2010.295     Document Type: Article

References (51)

1. Barker WW, Luis CA, Kashuba A, et al. Relative frequencies of Alzheimer disease, Lewy body, vascular and frontotemporal dementia, and hippocampal sclerosis in the State of Florida Brain Bank. Alzheimer Dis Assoc Disord. 2002;16(4):203-212. (Pubitemid 35434796)
2. Neary D, Snowden JS, Gustafson L, et al. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology. 1998;51(6):1546-1554.
3. Cairns NJ, Bigio EH, Mackenzie IR, et al; Consortium for Frontotemporal Lobar Degeneration. Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: consensus of the Consortium for Frontotemporal Lobar Degeneration. Acta Neuropathol. 2007;114(1):5-22. (Pubitemid 47029055)
4. Cairns NJ, Neumann M, Bigio EH, et al. TDP-43 in familial and sporadic frontotemporal lobar degeneration with ubiquitin inclusions. Am J Pathol. 2007;171(1):227-240. (Pubitemid 47342406)
5. Baker M, Mackenzie IR, Pickering-Brown SM, et al. Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17. Nature. 2006;442(7105):916-919.
6. Wilhelmsen KC. Frontotemporal dementia is on the MAPtau. Ann Neurol. 1997;41(2):139-140.
7. Skibinski G, Parkinson NJ, Brown JM, et al. Mutations in the endosomal ESCRTIII-complex subunit CHMP2B in frontotemporal dementia. Nat Genet. 2005;37(8):806-808. (Pubitemid 41077105)
8. Watts GD, Wymer J, Kovach MJ, et al. Inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia is caused by mutant valosin-containing protein. Nat Genet. 2004;36(4):377-381. (Pubitemid 38437260)
9. Cruts M, Gijselinck I, van der Zee J, et al. Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21. Nature. 2006;442(7105):920-924. (Pubitemid 44285947)
10. Morita M, Al-Chalabi A, Andersen PM, et al. A locus on chromosome 9p confers susceptibility to ALS and frontotemporal dementia. Neurology. 2006;66(6):839-844. (Pubitemid 43739757)
11. Vance C, Al-Chalabi A, Ruddy D, et al. Familial amyotrophic lateral sclerosis with frontotemporal dementia is linked to a locus on chromosome 9p13.2-21.3. Brain. 2006;129(pt 4):868-876.
12. Valdmanis PN, Dupre N, Bouchard JP, et al. Three families with amyotrophic lateral sclerosis and frontotemporal dementia with evidence of linkage to chromosome 9p [published correction appears in Arch Neurol. 2007;64(6):909]. Arch Neurol. 2007;64(2):240-245.
13. Hou CE, Carlin D, Miller BL. Non-Alzheimer's disease dementias: anatomic, clinical, and molecular correlates. Can J Psychiatry. 2004;49(3):164-171. (Pubitemid 38506494)
14. Pasquier F. Telling the difference between frontotemporal dementia and Alzheimer's disease. Curr Opin Psychiatry. 2005;18(6):628-632. (Pubitemid 41578730)
15. Pijnenburg YA, Gillissen F, Jonker C, Scheltens P. Initial complaints in frontotemporal lobar degeneration. Dement Geriatr Cogn Disord. 2004;17(4):302-306. (Pubitemid 38721146)
16. Varma AR, Snowden JS, Lloyd JJ, Talbot PR, Mann DM, Neary D. Evaluation of the NINCDS-ADRDA criteria in the differentiation of Alzheimer's disease and frontotemporal dementia. J Neurol Neurosurg Psychiatry. 1999;66(2):184-188. (Pubitemid 29103519)
17. Fernández Martínez M, Castro Flores J, Pérez de las Heras S, Mandaluniz Lekumberri A, Gordejuela Menocal M, Zarranz Imirizaldu JJ. Prevalence of neuropsychiatric symptoms in elderly patients with dementia in Mungialde County (Basque Country, Spain). Dement Geriatr Cogn Disord. 2008;25(2):103-108. (Pubitemid 351196121)
18. Velakoulis D, Walterfang M, Mocellin R, Pantelis C, McLean C. Frontotemporal dementia presenting as schizophrenia-like psychosis in young people: clinicopathological series and review of cases. Br J Psychiatry. 2009;194(4):298-305.
19. Woolley JD, Wilson MR, Hung E, Gorno-Tempini ML, Miller BL, Shim J. Frontotemporal dementia and mania. Am J Psychiatry. 2007;164(12):1811-1816. (Pubitemid 351739233)
20. Graham A, Davies R, Xuereb J, et al. Pathologically proven frontotemporal dementia presenting with severe amnesia. Brain. 2005;128(pt 3):597-605. (Pubitemid 40380194)
21. Gorno-Tempini ML, Brambati SM, Ginex V, et al. The logopenic/phonological variant of primary progressive aphasia. Neurology. 2008;71(16):1227-1234.
22. Kertesz A, Munoz DG. Primary progressive aphasia: a review of the neurobiology of a common presentation of Pick complex. Am J Alzheimers Dis Other Demen. 2002;17(1):30-36. (Pubitemid 34106523)
23. Alladi S, Xuereb J, Bak T, et al. Focal cortical presentations of Alzheimer's disease. Brain. 2007;130(pt 10):2636-2645. (Pubitemid 47511719)
24. Knibb JA, Xuereb JH, Patterson K, Hodges JR. Clinical and pathological characterization of progressive aphasia. Ann Neurol. 2006;59(1):156-165. (Pubitemid 43042882)
25. Farlow MR, Cummings JL. Effective pharmacologic management of Alzheimer's disease. Am J Med. 2007;120(5):388-397. (Pubitemid 46627453)
26. Vossel KA, Miller BL. New approaches to the treatment of frontotemporal lobar degeneration. Curr Opin Neurol. 2008;21(6):708-716.
27. Di Lazzaro V, Pilato F, Dileone M, et al. In vivo cholinergic circuit evaluation in frontotemporal and Alzheimer dementias. Neurology. 2006;66(7):1111-1113. (Pubitemid 44044806)
28. Procter AW, Qurne M, Francis PT. Neurochemical features of frontotemporal dementia. Dement Geriatr Cogn Disord. 1999;10(suppl 1):80-84. (Pubitemid 29348621)
29. Mendez MF, Shapira JS, McMurtray A, Licht E. Preliminary findings: behavioral worsening on donepezil in patients with frontotemporal dementia. Am J Geriatr Psychiatry. 2007;15(1):84-87. (Pubitemid 46106094)
30. Swanberg MM. Memantine for behavioral disturbances in frontotemporal dementia: a case series. Alzheimer Dis Assoc Disord. 2007;21(2):164-166. (Pubitemid 46878979)
31. Diehl-Schmid J, Förstl H, Perneczky R, Pohl C, Kurz A. A 6-month, open-label study of memantine in patients with frontotemporal dementia. Int J Geriatr Psychiatry. 2008;23(7):754-759.
32. Boxer AL, Lipton AM, Womack KB, et al. An open-label study of memantine treatment in 3 subtypes of frontotemporal lobar degeneration. Alzheimer Dis Assoc Disord. 2009;23(3):211-217.
33. Salloway S, Mintzer J, Weiner MF, Cummings JL. Disease-modifying therapies in Alzheimer's disease. Alzheimers Dement. 2008;4(2):65-79.
34. Seshadri S, Beiser A, Selhub J, et al. Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. N Engl J Med. 2002;346(7):476-483. (Pubitemid 34441738)
35. Short RA, Broderick DF, Patton A, Arvanitakis Z, Graff-Radford NR. Different patterns of magnetic resonance imaging atrophy for frontotemporal lobar degeneration syndromes. Arch Neurol. 2005;62(7):1106-1110. (Pubitemid 41043731)
36. Likeman M, Anderson VM, Stevens JM, et al. Visual assessment of atrophy on magnetic resonance imaging in the diagnosis of pathologically confirmed youngonset dementias. Arch Neurol. 2005;62(9):1410-1415. (Pubitemid 41352058)
37. Foster NL, Heidebrink JL, Clark CM, et al. FDG-PET improves accuracy in distinguishing frontotemporal dementia and Alzheimer's disease. Brain. 2007;130 (pt 10):2616-2635. (Pubitemid 47511706)
38. Minoshima S, Giordani B, Berent S, Frey KA, Foster NL, Kuhl DE. Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease. Ann Neurol. 1997;42(1):85-94. (Pubitemid 27304784)
39. Ishii K, Sakamoto S, Sasaki M, et al. Cerebral glucose metabolism in patients with frontotemporal dementia. J Nucl Med. 1998;39(11):1875-1878. (Pubitemid 28518885)
40. Burdette JH, Minoshima S, Vander Borght T, Tran DD, Kuhl DE. Alzheimer disease: improved visual interpretation of PET images by using three-dimensional stereotaxic surface projections. Radiology. 1996;198(3):837-843. (Pubitemid 26066307)
41. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977;33(1):159-174. (Pubitemid 8054849)
42. Friedland RP, Jagust WJ, Huesman RH, et al. Regional cerebral glucose transport and utilization in Alzheimer's disease. Neurology. 1989;39(11):1427-1434. (Pubitemid 19285995)
43. Beck J, Rohrer JD, Campbell T, et al. A distinct clinical, neuropsychological and radiological phenotype is associated with progranulin gene mutations in a large UK series. Brain. 2008;131(pt 3):706-720. (Pubitemid 351294713)
44. Le Ber I, Camuzat A, Hannequin D, et al; French Research Network on FTD/FTD-MND. Phenotype variability in progranulin mutation carriers: a clinical, neuropsychological, imaging and genetic study. Brain. 2008;131(pt 3):732-746. (Pubitemid 351294727)
45. Whitwell JL, Jack CR Jr, Baker M, et al. Voxel-based morphometry in fronto-temporal lobar degeneration with ubiquitin-positive inclusions with and without progranulin mutations. Arch Neurol. 2007;64(3):371-376. (Pubitemid 46425691)
46. Boxer AL, Geschwind MD, Belfor N, et al. Patterns of brain atrophy that differentiate corticobasal degeneration syndrome from progressive supranuclear palsy. Arch Neurol. 2006;63(1):81-86. (Pubitemid 43063865)
47. Juh R, Pae CU, Kim TS, Lee CU, Choe B, Suh T. Cerebral glucose metabolism in corticobasal degeneration comparison with progressive supranuclear palsy using statistical mapping analysis. Neurosci Lett. 2005;383(1-2):22-27. (Pubitemid 40779949)
48. Whitwell JL, Jack CR Jr, Boeve BF, et al. Voxel-based morphometry patterns of atrophy in FTLD with mutations in MAPT or PGRN. Neurology. 2009;72(9):813-820.
49. Rabinovici GD, Seeley WW, Kim EJ, et al. Distinct MRI atrophy patterns in autopsyproven Alzheimer's disease and frontotemporal lobar degeneration. Am J Alzheimers Dis Other Demen. 2007;22(6):474-488.
50. Seeley WW, Carlin DA, Allman JM, et al. Early frontotemporal dementia targets neurons unique to apes and humans. Ann Neurol. 2006;60(6):660-667. (Pubitemid 46048483)
51. Seeley WW, Crawford R, Rascovsky K, et al. Frontal paralimbic network atrophy in very mild behavioral variant frontotemporal dementia. Arch Neurol. 2008; 65(2):249-255. (Pubitemid 351240789)